TRAD CHI MED (00570) · Company profile · Eqvero

TRAD CHI MED

00570HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	14.74 bn CNY	16.51 bn CNY	18.12 bn CNY	14.3 bn CNY	19.05 bn CNY
Cost of revenue	6.49 bn CNY	7.52 bn CNY	7.71 bn CNY	6.01 bn CNY	6.37 bn CNY
Research and development expense	511.47 m CNY	596.01 m CNY	685.63 m CNY	611.83 m CNY	694.44 m CNY
Selling, general and administrative expense	6.07 bn CNY	6.48 bn CNY	7.45 bn CNY	5.55 bn CNY	8.56 bn CNY
Operating profit after depreciation	450.75 m CNY	751.9 m CNY	1.35 bn CNY	1.17 bn CNY	2.71 bn CNY
Operating profit before depreciation	1.61 bn CNY	1.88 bn CNY	2.48 bn CNY	2.27 bn CNY	3.56 bn CNY
EBIT	450.75 m CNY	751.9 m CNY	1.35 bn CNY	1.17 bn CNY	2.71 bn CNY
EBITDA	1.61 bn CNY	1.88 bn CNY	2.48 bn CNY	2.27 bn CNY	3.56 bn CNY
Interest expense	103.34 m CNY	171.54 m CNY	199.05 m CNY	220.7 m CNY	223.25 m CNY
Profit before tax	-368.23 m CNY	163.11 m CNY	1.22 bn CNY	840.11 m CNY	2.52 bn CNY
Income tax expense	89.86 m CNY	142.34 m CNY	-171.54 m CNY	119.36 m CNY	396.86 m CNY
Income before extraordinary items	-342.07 m CNY	54.07 m CNY	1.29 bn CNY	764.27 m CNY	1.93 bn CNY
Common dividends	—	16.12 m CNY	—	229.28 m CNY	580.95 m CNY
Total dividends	—	16.12 m CNY	—	229.28 m CNY	580.95 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.